You are administering an aerosolized bronchodilator to your patient. Her pretreatment pulse was 86 beats/min. You would stop the treatment if her pulse reached

________ is one of a group of illnesses called autoimmune diseases

a. SLE b. LSE c. ESL d. LES

According to ASHP guidelines, Risk level 1 includes all of the following products EXCEPT those that are:

A) Stored at room temperature and completely administered within 28 hours of preparation. B) Unpreserved, sterile, and prepared for administration to more than one patient and contain suitable preservatives. C) Prepared by a closed-system aseptic transfer of sterile, nonpyrogenic, finished pharmaceuticals obtained from licensed manufacturers into sterile final containers obtained from licensed manufacturers. D) Prepared by combining multiple ingredients, sterile or non-sterile, by using an open-system transfer before terminal sterilization.